Saturday 17 October 2026
Export PHIO’s income statement to Excel — free account
Phio Pharmaceuticals Corp.
PHIO Healthcare Biotechnology
In the quarter to June 2026, EPS grew 20.0% and free cash flow fell 58.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.87
0.06
−6.45%
Follow PHIO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
6.43 | 15.69 | 17.93 | 7.62 | |
Current Ratio |
6.90 | 16.03 | 18.32 | 8.39 | |
Net Debt/EBITDA |
4.27 | 8.30 | 4.09 | 3.05 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 0.88 | 1.00 | 0.98 | |
Capex/Depreciation |
(3.50) | 0.00 | 3.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.38) | (0.35) | (0.34) | (0.35) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.38) | (0.35) | (0.34) | (0.35) | |
Cash per Share |
1.96 | 3.51 | 1.47 | 1.12 | |
Shareholders Equity per Share |
1.80 | 3.37 | 1.42 | 1.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.80 | 3.37 | 1.42 | 1.08 | |
Free Cash Flow |
(2.09) | (2.08) | (4.00) | (4.03) | |
Working Capital |
9.83 | 20.14 | 16.45 | 12.59 | |
Capital Expenditures |
(0.01) | 0.00 | 0.00 | 0.00 | |
Net Current Asset Value |
9.83 | 20.14 | 16.45 | 12.59 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
0.35 | 0.34 | 0.34 | 0.57 | |
Average Assets |
8.69 | 13.61 | 15.43 | 12.80 | |
Average Common Equity |
7.39 | 12.44 | 14.32 | 11.35 |
Columns are period end dates